You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver Disease

    SBC: Metabolic Solutions Development Company, LLC            Topic: NIAAA

    DESCRIPTION (provided by applicant): Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease in the United States. This condition encompasses both hepatic steatosis and the more severe non-alcoholic steatohepatitis. It is now estimated that 14-24% of the general population and up to 80% of morbidly obese subjects have contracted NAFLD. Untreated disease may progress to cirrho ...

    STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  2. Creating Research Files from CMS Data for Integration with Survey Data

    SBC: ACUMEN LLC            Topic: NIA

    DESCRIPTION (provided by applicant): This STTR proposal to the National Institute on Aging (NIA) requests funding to expand the capabilities of the Medicare Research Information Center (MedRIC) recently established by Acumen, LLC with support from NIA. Thepurpose of MedRIC is to facilitate the acquisition and linking of data from the Centers for Medicare and Medicaid Services (CMS) to participants ...

    STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  3. Human Monoclonal Antibody To Treat P. aeruginosa Infections in Cystic Fibrosis

    SBC: Aridis Pharmaceuticals, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Over the past two decades, the number of new antimicrobials being developed has experienced a greater than 60% decline, while the number of antibiotic resistant microorganisms has been steadily increasing. Only one newantibacterial drug with a novel mechanism of action (linezolid) has been introduced during this period making the long term outlook for sustained ...

    STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  4. Human Rabies Virus Vaccine Development

    SBC: MOLECULAR TARGETING TECHNOLOGIES, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): Current human rabies virus (RV) vaccines are effective if administered in an appropriate and timely manner and therefore, RV infection is a vaccine-preventable disease. However, immunization protocols are complex, requiring multiple doses over a period of weeks and in some cases months. High costs and the lack of compliance associated with current vaccines, and ...

    STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  5. Automated Analysis of Skeletal Muscle Fiber Cross-sectional Area and Metabolic Ty

    SBC: VALA SCIENCES, INC.            Topic: NIAMS

    DESCRIPTION (provided by applicant): The accurate quantification of skeletal muscle morphology is desired in a wide variety of medical areas such as muscle regeneration, muscular dystrophy, exercise physiology, and nutrition. For such studies, skeletal muscle is often fixed, sectioned, and labeled to visualize the borders of the muscle fibers, and digitally photographed. Investigators then use lab ...

    STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  6. A New Web 2.0 Platform for Analyzing Genomics Data with Application to the S

    SBC: MYATT AND JOHNSON, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): A major research focus for gaining insight into the molecular basis for cancer, with the goal of identifying new treatments, is the systematic profiling of cancer cells. It has resulted in large volumes of data that include the compound potency and gene expression data. To more effectively find treatments, the data must be integrated and associated in context s ...

    STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  7. Broncho-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma

    SBC: MERCATOR MEDSYSTEMS, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Over 215,000 people will be diagnosed in 2008 with bronchial carcinoma in the U.S. according to the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. Currently, asthma afflicts22.9 million people in the U.S., and tracheomalacia is believed to afflict 3 million people in the U.S. In addition to these chronic or deadly c ...

    STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  8. Computer assisted disfluency counts for stuttered speech

    SBC: BIOSPEECH INC            Topic: NIDCD

    DESCRIPTION (provided by applicant): Stuttering is a communication disorder characterized by disfluencies that may be frequent or disruptive to communication. Clinicians make extensive use of disfluency counts, for diagnosis, to assess treatment progress,and to document treatment outcomes. SLPs mostly do disfluency counts in real-time as a client is talking. However, this approach only accounts fo ...

    STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  9. Nanotechnology Enabled Temporomandibular Joint(TMJ)Prosthesis

    SBC: VISTA ENGINEERING, INC.            Topic: NIDCR

    DESCRIPTION (provided by applicant): Temporomandibular Disorders (TMD) represent a collection of medical and dental conditions affecting the temporomandibular joint (TMJ) and/or the muscles of mastication, as well as contiguous tissue structures. For somepatients with severe TMJ degeneration, a prosthetic replacement may be required. However, long-term success and functioning of current implant d ...

    STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  10. Wearable Device for Continuous Hemodialysis

    SBC: VIVONICS INC            Topic: NIDDK

    DESCRIPTION: The fundamental goal of this program is to develop a microfluidics-based artificial kidney that minimizes exposure of blood to artificial surfaces and provides continuous perfusion in a compact, wearable device. This device will provide treatment at low flow rates over long times, greatly reducing concentration and volume transient in body fluids. The key element is a primary separato ...

    STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government